Want to join the conversation?
$BCR 2Q15 Call: PMA supplement for 120/150 mm balloon lengths was recently approved & received IDE approval, enrolled first few patients in AV access drug-coated balloon study. We're also working toward launch in 1H16 of next generation of both PowerGlide &AccuCath products. For acute hemodialysis patients, recently launched Trialysis Slim catheter
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.
$RAI has received a $47 billion take over offer from British tobacco giant British American Tobacco! This is huge!